1-3 of 3
Martin J. S. Dyer
Close
Sort by
Journal Articles

BTK mutations in patients with chronic lymphocytic leukemia receiving tirabrutinib

Ross A. Jackson, Robert G. Britton, Sandrine Jayne, Susann Lehmann, Caroline M. Cowley, Christopher S. Trethewey, Victoria M. Smith, Ralf Schmid, Christopher Fegan, Harriet S. Walter, Martin J. S. Dyer
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3378–3381.
https://doi.org/10.1182/bloodadvances.2022009366
Published: 2023
Includes: Supplemental data
Journal Articles

Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen

Clinical Trials & Observations
Meghan C. Thompson, Rosemary A. Harrup, Catherine C. Coombs, Lindsey E. Roeker, Jeffrey J. Pu, Michael Y. Choi, Paul M. Barr, John N. Allan, Martin Šimkovič, Lori Leslie, Joanna Rhodes, Elise A. Chong, Manali Kamdar, Alan Skarbnik, Frederick Lansigan, Brittany McCall, Khalid Saja, Martin J. S. Dyer, Harriet S. Walter, Marcus Lefebure, Maria Thadani-Mulero, Michelle Boyer, Juliana Biondo, Kavita Sail, Beenish S. Manzoor, Richard Furman, Kurt S. Bantilan, Andre Goy, Tatyana Feldman, Dominic Labella, Stephen J. Schuster, Jae Park, Lia Palomba, Andrew Zelenetz, Toby A. Eyre, Arnon P. Kater, John F. Seymour, Anthony R. Mato
Journal: Blood Advances
Blood Adv (2022) 6 (15): 4553–4557.
https://doi.org/10.1182/bloodadvances.2022007812
Published: 2022
Journal Articles

Dual dependence on BCL2 and MCL1 in T-cell prolymphocytic leukemia

Victoria M. Smith, Oliver Lomas, Donna Constantine, Lianne Palmer, Anna H. Schuh, David Bruce, Oksana Gonchar, Salvador Macip, Sandrine Jayne, Martin J. S. Dyer, Toby A. Eyre
Journal: Blood Advances
Blood Adv (2020) 4 (3): 525–529.
https://doi.org/10.1182/bloodadvances.2019000917
Published: 2020
Includes: Supplemental data